Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- Pharmaceuticals Industry
Nov 21, 2008 04:22 PM
- Onyx Pharma Bullish on Nexavar - Analyst Blog
Oct 22, 2008 02:31 PM
- Onyx Pharma - Bullish on Nexavar - Analyst Blog
Oct 22, 2008 12:08 PM
- UK Limits Quality of Life Drugs To £30,000 Per Year
Oct 11, 2008 09:15 PM
- Periodicals Wrap-Up for Friday, August 15th
Aug 15, 2008 09:50 AM
- Analyst Comments: Deutsche Bank, Acxiom, Amdocs, Chesapeake, Onyx Pharmaceuticals
Aug 07, 2008 01:52 AM
- Post Fed Earnings
Aug 06, 2008 10:38 AM
- Periodicals Wrap-Up for Wednesday, August 6th
Aug 06, 2008 09:59 AM
- Periodicals Wrap-Up for Thursday, July 31st
Jul 31, 2008 10:01 AM
- Periodicals Wrap-Up for Monday, July 28th
Jul 28, 2008 09:52 AM
- Zacks Bull and Bear of the Day Highlights: Tw Telecom, AutoNation, TDS, Iron Mountain and Onyx Pharmaceuticals
Nov 10, 2008 01:16 AM
- Onyx Pharmaceuticals Licenses Rights to Novel Targeted Oncology Agent From BTG International
Nov 06, 2008 04:30 PM
- Onyx Pharmaceuticals Reports Third Quarter and Nine-Month 2008 Financial Results
Nov 06, 2008 04:30 PM
- Onyx Pharmaceuticals to Present at the 2008 Credit Suisse Health Care Conference
Nov 05, 2008 04:00 PM
- New Analyses Confirm Nexavar's Efficacy and Safety in Multiple Patient Subsets With Liver Cancer
Oct 31, 2008 08:01 AM
- Onyx Pharmaceuticals Announces Third Quarter 2008 Financial Results Teleconference and Webcast
Oct 29, 2008 04:01 PM
- Bayer and Onyx Launch Educational Program to Raise Awareness About Liver Cancer and Its Risk Factors
Oct 28, 2008 08:03 AM
- Zacks Analyst Blog Highlights: Schlumberger Ltd., Amylin Pharmaceuticals, Inc., Eli Lilly & Co., Onyx Pharmaceuticals, Inc. And Diageo Plc.
Oct 23, 2008 07:15 AM
- Onyx Pharmaceuticals to Present at UBS Global Life Sciences Conference
Sep 18, 2008 04:00 PM
- Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer
Aug 21, 2008 08:02 AM
- Form 4 FUCHS HENRY J For: Nov 18 (10K)
Nov 19, 2008 04:33 PM
- Form 4 ONYX PHARMACEUTICALS For: Nov 07 Filed by: Brege Laura (10K)
Nov 10, 2008 08:49 PM
- Form 4 ONYX PHARMACEUTICALS For: Nov 06 Filed by: Lasowski Juergen (10K)
Nov 10, 2008 08:49 PM
- Form 4 ONYX PHARMACEUTICALS For: Oct 06 Filed by: LYLE CORINNE H (10K)
Oct 07, 2008 09:32 PM
- Form 3 ONYX PHARMACEUTICALS For: Sep 30 Filed by: Batlin Judy A (10K)
Oct 07, 2008 09:32 PM
- Form 4 ONYX PHARMACEUTICALS For: Oct 01 Filed by: WOOD JULIANNA R (10K)
Oct 02, 2008 08:47 PM
- Form 4 ONYX PHARMACEUTICALS For: Sep 18 Filed by: SCHAFER GREGORY W (10K)
Sep 22, 2008 02:14 PM
- Form 4 FUCHS HENRY J For: Sep 15 (10K)
Sep 16, 2008 06:13 PM
- Form 4 ONYX PHARMACEUTICALS For: Aug 27 Filed by: WIERENGA WENDALL (10K)
Aug 27, 2008 08:26 PM
- Form 4 ONYX PHARMACEUTICALS For: Aug 18 Filed by: WOOD JULIANNA R (10K)
Aug 20, 2008 07:46 PM
Analyst Ratings
|
|
Share Performance
|
Period
|
ONXX
|
Compare to S&P
|
| YTD |
-51.83 %
|
-0.01 %
|
| 4 Weeks |
-3.15 %
|
14.76 %
|
| 12 Weeks |
-26.36 %
|
6.23 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 162.50 %
|
|
EPS Growth in Last Year: 2,000.00 %
|
|
Sales Growth in Last Quarter: -0.01 %
|
|
Sales Growth in Last Quarter: -0.01 %
|
|
|
